QGH-23418-12770 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-28
Registered in v-safe
2021-01-28
Dose 1 — Pfizer-BioNTech
2021-01-29
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-01-30
Health check-in — days 1–6 daily, dose 1
Feeling: Poor · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-01-30
Report sent to call center — days 1–6 daily, dose 1
Be unable to work · Be unable to do your normal daily activities

1 call case(s)
2021-01-31
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Headache

Adult check-in
2021-02-01
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-02-18
Dose 2 — Pfizer-BioNTech
2021-02-19
Survey response — days 1–6 daily, dose 2
MedDRA: Pregnancy — Feeling: Poor · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Free text: Pregnancy

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-21
Survey response — days 1–6 daily, dose 2
MedDRA: Pregnancy — Feeling: Fair · Chills, Fatigue or tiredness · Be unable to do your normal daily activities

Free text: Pregnant

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-08-22
Survey response — 6 months, dose 2
MedDRA: Gestational hypertension, Postpartum disorder, Pre-eclampsia, Premature delivery — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, Hospitalization

Free text: Developed gestational hypertension, pre-eclampsia, delivered premature baby and postpartum pre-eclampsia in 2nd pregnancy, no similar issues in first pregnancy.

MedDRA releases: 2021-09,2024-11 · check-in free text available
2021-08-22
Report sent to call center — 6 months, dose 2
Be unable to work or attend school · Get care from a doctor or other healthcare professional

1 call case(s)
2021-08-24
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-28	Pfizer-BioNTech
2	2021-02-18	Pfizer-BioNTech

Call center

2 call center cases

1 unsuccessful · 1 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 4 — days 1–6 daily, dose 2

2021-02-19

Systemic reaction (other): Pregnancy

2021-02-21

Systemic reaction (other): Pregnant

Release 9 — 6 months, dose 2

2021-08-22

Symptoms: Developed gestational hypertension, pre-eclampsia, delivered premature baby and postpartum pre-eclampsia in 2nd pregnancy, no similar issues in first pregnancy.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Gestational hypertension	✓	·	✓
SD	Postpartum disorder	✓	·	✓
SD	Pre-eclampsia	✓	·	✓
SD	Premature delivery	✓	·	✓
SRO	Pregnancy	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release